Lichenoid eruption produced by captopril
Captopril, an oral active dipeptidylcarboxypeptidase inhibitor with antihypertensive properties, has been reported to have the following cutaneous side effects: macular and papular skin eruptions, urticaria, angioedema, mouth ulcers, pemphigus, and pityriasis rosea-like eruptions. Here, to the best...
Saved in:
Published in | Cutis (New York, N.Y.) Vol. 31; no. 1; p. 98 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
01.01.1983
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | Captopril, an oral active dipeptidylcarboxypeptidase inhibitor with antihypertensive properties, has been reported to have the following cutaneous side effects: macular and papular skin eruptions, urticaria, angioedema, mouth ulcers, pemphigus, and pityriasis rosea-like eruptions. Here, to the best of our knowledge, is the first case in which a pityriasis rosea-like eruption evolved into a lichenoid drug eruption. Also discussed is the remarkable similarity in the side effects of captopril, gold compounds, d-penicillamine, and organic mercurials. |
---|---|
ISSN: | 0011-4162 |